Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
September-2022 Volume 50 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2022 Volume 50 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review)

  • Authors:
    • Oliver Dean John
    • Annals Tatenda Mushunje
    • Noumie Surugau
    • Rhanye Mac Guad
  • View Affiliations / Copyright

    Affiliations: Faculty of Science and Natural Resources, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia, Faculty of Science, Asia‑Pacific International University, Muak Lek, Saraburi 18180, Thailand, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia
    Copyright: © John et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 120
    |
    Published online on: July 27, 2022
       https://doi.org/10.3892/ijmm.2022.5176
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

α‑mangostin is a xanthone predominantly encountered in Garcinia mangostana. Extensive research has been carried out concerning the effects of this compound on various diseases, including obesity, cancer and metabolic disorders. The present review suggests that α‑mangostin exerts promising anti‑obesity, hepatoprotective, antidiabetic, cardioprotective, antioxidant and anti‑inflammatory effects on various pathways in cardiometabolic diseases. The anti‑obesity effects of α‑mangostin include the reduction of body weight and adipose tissue size, the increase in fatty acid oxidation, the activation of hepatic AMP‑activated protein kinase and Sirtuin‑1, and the reduction of peroxisome proliferator‑activated receptor γ expression. Hepatoprotective effects have been revealed, due to reduced fibrosis through transforming growth factor‑β 1 pathways, reduced apoptosis and steatosis through reduced sterol regulatory‑element binding proteins expression. The antidiabetic effects include decreased fasting blood glucose levels, improved insulin sensitivity and the increased expression of GLUT transporters in various tissues. Cardioprotection is exhibited through the restoration of cardiac functions and structure, improved mitochondrial functions, the promotion of M2 macrophage populations, reduced endothelial and cardiomyocyte apoptosis and fibrosis, and reduced acid sphingomyelinase activity and ceramide depositions. The antioxidant effects of α‑mangostin are mainly related to the modulation of antioxidant enzymes, the reduction of oxidative stress markers, the reduction of oxidative damage through a reduction in Sirtuin 3 expression mediated by phosphoinositide 3‑kinase/protein kinase B/peroxisome proliferator‑activated receptor‑γ coactivator‑1α signaling pathways, and to the increase in Nuclear factor‑erythroid factor 2‑related factor 2 and heme oxygenase‑1 expression levels. The anti‑inflammatory effects of α‑mangostin include its modulation of nuclear factor‑κB related pathways, the suppression of mitogen‑activated protein kinase activation, increased macrophage polarization to M2, reduced inflammasome occurrence, increased Sirtuin 1 and 3 expression, the reduced expression of inducible nitric oxide synthase, the production of nitric oxide and prostaglandin E2, the reduced expression of Toll‑like receptors and reduced proinflammatory cytokine levels. These effects demonstrate that α‑mangostin may possess the properties required for a suitable candidate compound for the management of cardiometabolic diseases.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr and Lenfant C; American Heart Association: National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: Report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation. 109:433–438. 2004. View Article : Google Scholar : PubMed/NCBI

2 

Pite H, Aguiar L, Morello J, Monteiro EC, Alves AC, Bourbon M and Morais-Almeida M: Metabolic dysfunction and asthma: Current perspectives. J Asthma Allergy. 13:237–247. 2020. View Article : Google Scholar : PubMed/NCBI

3 

O'Neill S and O'Driscoll L: Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes Rev. 16:1–12. 2015. View Article : Google Scholar

4 

ASMBS Clinical Issues Committee: Bariatric surgery in class I obesity (body mass index 30-35 kg/m2). Surg Obes Relat Dis. 9:e1–e10. 2013. View Article : Google Scholar

5 

Hill JO, Wyatt HR and Peters JC: Energy balance and obesity. Circulation. 126:126–132. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C and Beguinot F: Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 10:16072020. View Article : Google Scholar : PubMed/NCBI

7 

Zafar U, Khaliq S, Ahmad HU, Manzoor S and Lone KP: Metabolic syndrome: An update on diagnostic criteria, pathogenesis, and genetic links. Hormones (Athens). 17:299–313. 2018. View Article : Google Scholar

8 

Halpern A, Pepe RB, Monegaglia AP, Beyruti M, de Melo ME and Mancini MC: Efficacy and tolerability of the association of sibutramine and orlistat for six months in overweight and obese patients. J Obes. 2010:6025372010. View Article : Google Scholar : PubMed/NCBI

9 

Francini-Pesenti F, Spinella P and Calò LA: Potential role of phytochemicals in metabolic syndrome prevention and therapy. Diabetes Metab Syndr Obes. 12:1987–2002. 2019. View Article : Google Scholar : PubMed/NCBI

10 

Liu QY, Wang YT and Lin LG: New insights into the anti-obesity activity of xanthones from Garcinia mangostana. Food Funct. 6:383–393. 2015. View Article : Google Scholar

11 

John OD, Brown L and Panchal SK: Garcinia fruits: Their potential to combat metabolic syndrome. Nutraceuticals and Natural Product Derivatives: Disease Prevention & Drug Discovery. Ullah MF and Ahmad A: John Wiley & Sons, Inc; Hoboken, NJ: pp. 39–80. 2019

12 

John OD, Mouatt P, Panchal SK and Brown L: Rind from purple mangosteen (Garcinia mangostana) attenuates diet-induced physiological and metabolic changes in obese rats. Nutrients. 13:3192021. View Article : Google Scholar :

13 

Ee GC, Daud S, Taufiq-Yap YH, Ismail NH and Rahmani M: Xanthones from Garcinia mangostana (Guttiferae). Nat Prod Res. 20:1067–1073. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Khamthong N and Hutadilok-Towatana N: Phytoconstituents and biological activities of Garcinia dulcis (Clusiaceae): A review. Nat Prod Commun. 12:453–460. 2017.PubMed/NCBI

15 

Ngoupayo J, Tabopda TK and Ali MS: Antimicrobial and immunomodulatory properties of prenylated xanthones from twigs of Garcinia staudtii. Bioorg Med Chem. 17:5688–5695. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Kijjoa A, Gonzalez MJ, Pinto MM, Nascimento MS, Campos N, Mondranondra IO, Silva AM, Eaton G and Herz W: Cytotoxicity of prenylated xanthones and other constituents from the wood of Garcinia merguensis. Planta Med. 74:864–866. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Fatma Sri W, Daud Ahmad Israf A, Nordin Hj L and Dachriyanus: Anti-inflammatory activity of isolated compounds from the stem bark of Garcinia cowa Roxb. Pharmacogn J. 9:55–57. 2017.

18 

Phuwapraisirisan P, Udomchotphruet S, Surapinit S and Tip-Pyang S: Antioxidant xanthones from Cratoxylum cochinchinense. Nat Prod Res. 20:1332–1337. 2006. View Article : Google Scholar

19 

Ibrahim MY, Hashim NM, Mohan S, Abdulla MA, Abdelwahab SI, Arbab IA, Yahayu M, Ali LZ and Ishag OE: α-Mangostin from Cratoxylum arborescens: An in vitro and in vivo toxicological evaluation. Arab J Chem. 8:129–137. 2015. View Article : Google Scholar

20 

Thaweboon S, Thaweboon B, Nisalak P and Kaypetch R: Inhibitory effect of Cratoxylum formosum gum on candida glabrata and its α-mangostin content. MATEC Web Conf. 65:030042016. View Article : Google Scholar

21 

Lenta BN, Kamdem LM, Ngouela S, Tantangmo F, Devkota KP, Boyom FF, Rosenthal PJ and Tsamo E: Antiplasmodial constituents from the fruit pericarp of Pentadesma butyracea. Planta Med. 77:377–379. 2011. View Article : Google Scholar

22 

Ghasemzadeh A, Jaafar HZE, Baghdadi A and Tayebi-Meigooni A: Alpha-mangostin-rich extracts from mangosteen pericarp: Optimization of green extraction protocol and evaluation of biological activity. Molecules. 23:18522018. View Article : Google Scholar :

23 

Pedraza-Chaverri J, Cárdenas-Rodríguez N, Orozco-Ibarra M and Pérez-Rojas JM: Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol. 46:3227–3239. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Choi YH, Bae JK, Chae HS, Kim YM, Sreymom Y, Han L, Jang HY and Chin YW: α-Mangostin regulates hepatic steatosis and obesity through SirT1-AMPK and PPARγ pathways in high-fat diet-induced obese mice. J Agric Food Chem. 63:8399–8406. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Kim HM, Kim YM, Huh JH, Lee ES, Kwon MH, Lee BR, Ko HJ and Chung CH: α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2. PLoS One. 12:e01792042017. View Article : Google Scholar

26 

Vien LC, Chinnappan S and Mogana R: Antioxidant activity of Garcinia mangostana L and alpha mangostin: A review. Res J Pharm Technol. 14:4466–4470. 2021. View Article : Google Scholar

27 

Pan T, Chen R, Wu D, Cai N, Shi X, Li B and Pan J: Alpha-mangostin suppresses interleukin-1β-induced apoptosis in rat chondrocytes by inhibiting the NF-κB signaling pathway and delays the progression of osteoarthritis in a rat model. Int Immunopharmacol. 52:156–162. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Chae HS, Oh SR, Lee HK, Joo SH and Chin YW: Mangosteen xanthones, α-and γ-mangostins, inhibit allergic mediators in bone marrow-derived mast cell. Food Chem. 134:397–400. 2012. View Article : Google Scholar

29 

Li P, Tian W and Ma X: Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells. Mol Cancer. 13:1382014. View Article : Google Scholar : PubMed/NCBI

30 

Yang A, Liu C, Wu J, Kou X and Shen R: A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease. Eur J Pharmacol. 897:1739502021. View Article : Google Scholar

31 

Rodniem S, Tiyao V, Nilbu-Nga C, Poonkhum R, Pongmayteegul S and Pradidarcheep W: Protective effect of alpha-mangostin on thioacetamide-induced liver fibrosis in rats as revealed by morpho-functional analysis. Histol Histopathol. 34:419–430. 2019.

32 

Sampath PD and Vijayaragavan K: Ameliorative prospective of alpha-mangostin, a xanthone derivative from Garcinia mangostana against beta-adrenergic cathecola-mine-induced myocardial toxicity and anomalous cardiac TNF-α and COX-2 expressions in rats. Exp Toxicol Pathol. 60:357–364. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Sivaranjani M, Prakash M, Gowrishankar S, Rathna J, Pandian SK and Ravi AV: In vitro activity of alpha-mangostin in killing and eradicating Staphylococcus epidermidis RP62A biofilms. Appl Microbiol Biotechnol. 101:3349–3359. 2017. View Article : Google Scholar : PubMed/NCBI

34 

Kaomongkolgit R, Jamdee K and Chaisomboon N: Antifungal activity of alpha-mangostin against Candida albicans. J Oral Sci. 51:401–406. 2009. View Article : Google Scholar : PubMed/NCBI

35 

Zhang KJ, Gu QL, Yang K, Ming XJ and Wang JX: Anticarcinogenic effects of α-mangostin: A review. Planta Med. 83:188–202. 2017.

36 

Chen G, Li Y, Wang W and Deng L: Bioactivity and pharmacological properties of α-mangostin from the mangosteen fruit: A review. Expert Opin Ther Pat. 28:415–427. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Ibrahim MY, Hashim NM, Mariod AA, Mohan S, Abdulla MA, Abdelwahab SI and Arbab IA: α-Mangostin from Garcinia mangostana Linn: An updated review of its pharmacological properties. Arab J Chem. 9:317–329. 2016. View Article : Google Scholar

38 

Jindarat S: Xanthones from mangosteen (Garcinia mangostana): Multi-targeting pharmacological properties. J Med Assoc Thai. 97(Suppl 2): S196–S201. 2014.PubMed/NCBI

39 

Tousian Shandiz H, Razavi BM and Hosseinzadeh H: Review of Garcinia mangostana and its xanthones in metabolic syndrome and related complications. Phytother Res. 31:1173–1182. 2017. View Article : Google Scholar : PubMed/NCBI

40 

Wang MH, Zhang KJ, Gu QL, Bi XL and Wang JX: Pharmacology of mangostins and their derivatives: A comprehensive review. Chin J Nat Med. 15:81–93. 2017.PubMed/NCBI

41 

Abuzaid AS, Sukandar E, Kurniati NF and Adnyana IK: Preventive effect on obesity of mangosteen (Garcinia mangostana L.) pericarp ethanolic extract by reduction of fatty acid synthase level in monosodium glutamate and high-calorie diet-induced male wistar rats. Asian J Pharm Clin Res. 9:257–260. 2016.

42 

Li D, Liu Q, Lu X, Li Z, Wang C, Leung CH, Wang Y, Peng C and Lin L: α-Mangostin remodels visceral adipose tissue inflammation to ameliorate age-related metabolic disorders in mice. Aging (Albany NY). 11:11084–11110. 2019. View Article : Google Scholar

43 

Tsai SY, Chung PC, Owaga EE, Tsai IJ, Wang PY, Tsai JI, Yeh TS and Hsieh RH: Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis. Nutr Metab (Lond). 13:882016. View Article : Google Scholar

44 

Muhamad Adyab NS, Rahmat A, Abdul Kadir NAA, Jaafar H, Shukri R and Ramli NS: Mangosteen (Garcinia mangostana) flesh supplementation attenuates biochemical and morphological changes in the liver and kidney of high fat diet-induced obese rats. BMC Complement Altern Med. 19:3442019. View Article : Google Scholar : PubMed/NCBI

45 

Chae HS, Kim YM, Bae JK, Sorchhann S, Yim S, Han L, Paik JH, Choi YH and Chin YW: Mangosteen extract attenuates the metabolic disorders of high-fat-fed mice by activating AMPK. J Med Food. 19:148–154. 2016. View Article : Google Scholar

46 

Mohamed SM, Mohammed DS, Abd Elhaliem NG, Elbadry MI and Abu-Dief EE: Mangosteen can improve steatohepatitis through modulating inflammatory and autophagy/apoptosis cell injury: An animal model study. Cytol Genet. 55:480–490. 2021. View Article : Google Scholar

47 

Klop B, Elte JWF and Cabezas MC: Dyslipidemia in obesity: Mechanisms and potential targets. Nutrients. 5:1218–1240. 2013. View Article : Google Scholar : PubMed/NCBI

48 

Taher M, Mohamed Amiroudine MZ, Tengku Zakaria TM, Susanti D, Ichwan SJ, Kaderi MA, Ahmed QU and Zakaria ZA: α-Mangostin improves glucose uptake and inhibits adipocytes differentiation in 3T3-L1 cells via PPARγ, GLUT4, and leptin expressions. Evid Based Complementary Altern Med. 2015:7402382015. View Article : Google Scholar

49 

Chae HS, Kim EY, Han L, Kim NR, Lam B, Paik JH, Yoon KD, Choi YH and Chin YW: Xanthones with pancreatic lipase inhibitory activity from the pericarps of Garcinia mangostana L.(Guttiferae). Eur J Lipid Sci Technol. 118:1416–1421. 2016. View Article : Google Scholar

50 

Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P and Auwerx J: AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 458:1056–1060. 2009. View Article : Google Scholar : PubMed/NCBI

51 

Fu Z, R Gilbert E and Liu D: Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev. 9:25–53. 2013. View Article : Google Scholar

52 

Lee D, Kim YM, Jung K, Chin YW and Kang KS: Alpha-mangostin improves insulin secretion and protects INS-1 cells from streptozotocin-induced damage. Int J Mol Sci. 19:14842018. View Article : Google Scholar :

53 

Langlais P, Yi Z, Finlayson J, Luo M, Mapes R, De Filippis E, Meyer C, Plummer E, Tongchinsub P, Mattern M and Mandarino LJ: Global IRS-1 phosphorylation analysis in insulin resistance. Diabetologia. 54:2878–2889. 2011. View Article : Google Scholar : PubMed/NCBI

54 

De Meyts P: The insulin receptor and its signal transduction network. Endotext [Internet]. MDText.com, Inc. South Dartmouth, MA: 2016

55 

Taniguchi CM, Emanuelli B and Kahn CR: Critical nodes in signalling pathways: Insights into insulin action. Nat Rev Mol Cell Biol. 7:85–96. 2006. View Article : Google Scholar : PubMed/NCBI

56 

Okada S, Crosson S, Mori M, Saltiel AR and Pessin JE: Insulin action, post-receptor mechanisms. Encyclopedia of Endocrine Diseases. Martini L: Elsevier; pp. 14–22. 2004, View Article : Google Scholar

57 

Accili D and Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 117:421–426. 2004. View Article : Google Scholar : PubMed/NCBI

58 

Zhang Y, Mei H, Shan W, Shi L, Chang X, Zhu Y, Chen F and Han X: Lentinan protects pancreatic β cells from STZ-induced damage. J Cell Mol Med. 20:1803–1812. 2016. View Article : Google Scholar : PubMed/NCBI

59 

Luo Y and Lei M: α-Mangostin protects against high-glucose induced apoptosis of human umbilical vein endothelial cells. Biosci Rep. 37:BSR201707792017. View Article : Google Scholar

60 

Volpe CMO, Villar-Delfino PH, Dos Anjos PMF and Nogueira-Machado JA: Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 9:1192018. View Article : Google Scholar : PubMed/NCBI

61 

Husen SA, Salamun, Ansori ANM, Joko R, Susilo K, Hayaza S and Winarni D: The effect of alpha-mangostin in glucose level, cholesterol level and diameter of the islets of langerhans of STZ-induced diabetic mice. In: Proceedings of the 2nd International Conference Postgraduate School (ICPS 2018); Science and Technology Publications, Lda; pp. 561–566. 2018

62 

Kurniawati M, Mahdi C and Aulanni'am A: The effect of juice mangosteen rind (Garcinia mangostana L.) to blood sugar levels and histological of pancreatic rats with the induction of streptozotocin. J Pure App Chem Res. 3:1–6. 2014. View Article : Google Scholar

63 

Jariyapongskul A, Areebambud C, Suksamrarn S and Mekseepralard CJBri: Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats. Biomed Res Int. 2015:7858262015. View Article : Google Scholar : PubMed/NCBI

64 

Paul S, Ali A and Katare R: Molecular complexities underlying the vascular complications of diabetes mellitus-a comprehensive review. J Diabetes Complications. 34:1076132020. View Article : Google Scholar

65 

Djeujo FM, Francesconi V, Gonella M, Ragazzi E, Tonelli M and Froldi G: Anti-α-glucosidase and antiglycation activities of α-mangostin and new xanthenone derivatives: Enzymatic kinetics and mechanistic insights through in vitro studies. Molecules. 27:5472022. View Article : Google Scholar

66 

Kumar V, Bhatt PC, Kaithwas G, Rashid M, Al-abbasi F, Khan J, Anwar F and Verma A: α-Mangostin mediated pharmacological modulation of hepatic carbohydrate metabolism in diabetes induced Wistar rat. Beni-Suef Univ J Basic Appl Sci. 5:255–276. 2016.

67 

Watanabe M, Gangitano E, Francomano D, Addessi E, Toscano R, Costantini D, Tuccinardi D, Mariani S, Basciani S, Spera G, et al: Mangosteen extract shows a potent insulin sensitizing effect in obese female patients: A prospective randomized controlled pilot study. Nutrients. 10:5862018. View Article : Google Scholar :

68 

Ratwita W, Sukandar EY, Adnyana IK and Kurniati NF: Alpha mangostin and xanthone from Mangosteen (Garcinia mangostana L.) role on glucose tolerance and glucose transporter-4 in diabetes mellitus. Int J Pharmacogn Phytochem Res. 9:1206–1212. 2017.

69 

Rusman JRA, Sundari SA, Nuriliani A and Saragih HT: Ameliorative effect of Mangosteen (Garcinia mangostana L.) peel infusion on the histopathological structures of the liver and kidney of rats (Rattus norvegicus Berkenhout, 1769) after H2O2 induction. Vet World. 14:1579–1587. 2021. View Article : Google Scholar : PubMed/NCBI

70 

Hassan AA, Moustafa EM, EL-Khashab IH and Mansour SZ: Mangosteen hinders gamma radiation-mediated oxidative stress and liver injury by down-regulating TNF-α/NF-κB and pro-fibrotic factor TGF-β1 inducing inflammatory signaling. Dose Response. 19:155932582110251902021. View Article : Google Scholar

71 

Yan XT, Sun YS, Ren S, Zhao LC, Liu WC, Chen C, Wang Z and Li W: Dietary α-mangostin provides protective effects against acetaminophen-induced hepatotoxicity in mice via Akt/mTOR-mediated inhibition of autophagy and apoptosis. Int J Mol Sci. 19:13352018. View Article : Google Scholar

72 

Fu T, Li H, Zhao Y, Cai E, Zhu H, Li P and Liu J: Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice. Biomed Pharmacother. 106:896–901. 2018. View Article : Google Scholar : PubMed/NCBI

73 

Abood WN, Bradosty SW, Shaikh FK, Salehen N, Farghadani R, Agha FS, Al-Medhtiy MH, Kamil TDA, Agha S, Abdulla MA, et al: Garcinia mangostana peel extracts exhibit hepatoprotective activity against thioacetamide-induced liver cirrhosis in rats. J Funct Foods. 74:1042002020. View Article : Google Scholar

74 

Dewidar B, Meyer C, Dooley S and Meindl-Beinker N: TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 8:14192019. View Article : Google Scholar

75 

Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K and Wakasa K: In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol. 37:56–62. 2002. View Article : Google Scholar : PubMed/NCBI

76 

Yang L, Li P, Fu S, Calay ES and Hotamisligil GS: Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11:467–478. 2010. View Article : Google Scholar : PubMed/NCBI

77 

Inami Y, Yamashina S, Izumi K, Ueno T, Tanida I, Ikejima K and Watanabe S: Hepatic steatosis inhibits autophagic proteolysis via impairment of autophagosomal acidification and cathepsin expression. Biochem Biophys Res Commun. 412:618–625. 2011. View Article : Google Scholar : PubMed/NCBI

78 

Sinha RA, You SH, Zhou J, Siddique MM, Bay BH, Zhu X, Privalsky ML, Cheng SY, Stevens RD, Summers SA, et al: Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest. 122:2428–2438. 2012. View Article : Google Scholar : PubMed/NCBI

79 

Jiang M, Huang S, Duan W, Liu Q and Lei M: Alpha-mangostin improves endothelial dysfunction in db/db mice through inhibition of aSMase/ceramide pathway. J Cell Mol Med. 25:3601–3609. 2021. View Article : Google Scholar : PubMed/NCBI

80 

Rahmaniah R, Yuyuntia Y, Soetikno V, Arozal W, Antarianto RD and Louisa M: Alpha mangostin inhibits hepatic stellate cells activation through TGF-β/smad and AKT signaling pathways: An in vitro study in LX2. Drug Res (Stuttg). 8:153–158. 2018.

81 

Shibata MA, Harada-Shiba M, Shibata E, Tosa H, Matoba Y, Hamaoka H, Iinuma M and Kondo Y: Crude α-mangostin suppresses the development of atherosclerotic lesions in apoe-deficient mice by a possible M2 macrophage-mediated mechanism. Int J Mol Sci. 20:17222019. View Article : Google Scholar

82 

Lestari N, Louisa M, Soetikno V, Suwana AG, Ramadhan PA, Akmal T and Arozal W: Alpha mangostin inhibits the proliferation and activation of acetaldehyde induced hepatic stellate cells through TGF-β and ERK 1/2 pathways. J Toxicol. 2018:53604962018. View Article : Google Scholar

83 

Chae HS, Kim HJ, Ko HJ, Lee CH, Choi YH and Chin YW: Transcriptome analysis illuminates a hub role of SREBP2 in cholesterol metabolism by α-mangostin. ACS Omega. 5:31126–31136. 2020. View Article : Google Scholar : PubMed/NCBI

84 

Boonprom P, Boonla O, Chayaburakul K, Welbat JU, Pannangpetch P, Kukongviriyapan U, Kukongviriyapan V, Pakdeechote P and Prachaney P: Garcinia mangostana pericarp extract protects against oxidative stress and cardiovascular remodeling via suppression of p47phox and iNOS in nitric oxide deficient rats. Ann Anat. 212:27–36. 2017. View Article : Google Scholar : PubMed/NCBI

85 

Sampath PD and Kannan V: Mitigation of mitochondrial dysfunction and regulation of eNOS expression during experimental myocardial necrosis by alpha-mangostin, a xanthonic derivative from Garcinia mangostana. Drug Chem Toxicol. 32:344–352. 2009. View Article : Google Scholar : PubMed/NCBI

86 

Jittiporn K, Moongkarndi P, Samer J and Suvitayavat W: Protective effect of α-mangostin on high glucose induced endothelial cell apoptosis. Walailak J Sci Technol. 15:579–587. 2018. View Article : Google Scholar

87 

Tousian H, Razavi BM and Hosseinzadeh H: Alpha-mangostin decreased cellular senescence in human umbilical vein endothelial cells. Daru. 28:45–55. 2020. View Article : Google Scholar :

88 

Fang Z, Luo W and Luo Y: Protective effect of α-mangostin against CoCl2-induced apoptosis by suppressing oxidative stress in H9C2 rat cardiomyoblasts. Mol Med Rep. 17:6697–6704. 2018.PubMed/NCBI

89 

Chen LG, Yang LL and Wang CC: Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol. 46:688–693. 2008. View Article : Google Scholar

90 

Förstermann U, Xia N and Li H: Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 120:713–735. 2017. View Article : Google Scholar : PubMed/NCBI

91 

Chaurasia B and Summers SA: Ceramides-lipotoxic inducers of metabolic disorders. Trends Endocrinol Metab. 26:538–550. 2015. View Article : Google Scholar : PubMed/NCBI

92 

Okudaira C, Ikeda Y, Kondo S, Furuya S, Hirabayashi Y, Koyano T, Saito Y and Umezawa K: Inhibition of acidic sphingomyelinase by xanthone compounds isolated from Garcinia speciosa. J Enzyme Inhib. 15:129–138. 2000. View Article : Google Scholar : PubMed/NCBI

93 

Idris-Khodja N, Ouerd S, Mian MOR, Gornitsky J, Barhoumi T, Paradis P and Schiffrin EL: Endothelin-1 overexpression exaggerates diabetes-induced endothelial dysfunction by altering oxidative stress. Am J Hypertens. 29:1245–1251. 2016. View Article : Google Scholar : PubMed/NCBI

94 

Schneider JG, Tilly N, Hierl T, Sommer U, Hamann A, Dugi K, Leidig-Bruckner G and Kasperk C: Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens. 15:967–972. 2002. View Article : Google Scholar : PubMed/NCBI

95 

Eisvand F, Imenshahidi M, Ghasemzadeh Rahbardar M, Tabatabaei Yazdi SA, Rameshrad M, Razavi BM and Hosseinzadeh H: Cardioprotective effects of alpha-mangostin on doxorubicin-induced cardiotoxicity in rats. Phytother Res. 36:506–524. 2022. View Article : Google Scholar

96 

Wu Y, Pan N, An Y, Xu M, Tan L and Zhang L: Diagnostic and prognostic biomarkers for myocardial infarction. Front Cardiovasc Med. 7:6172772021. View Article : Google Scholar : PubMed/NCBI

97 

Aydin S, Ugur K, Aydin S, Sahin İ and Yardim M: Biomarkers in acute myocardial infarction: Current perspectives. Vasc Health Risk Manag. 15:1–10. 2019. View Article : Google Scholar : PubMed/NCBI

98 

Soetikno V, Murwantara A, Andini P, Charlie F, Lazarus G, Louisa M and Arozal W: Alpha-mangostin improves cardiac hypertrophy and fibrosis and associated biochemical parameters in high-fat/high-glucose diet and low-dose streptozotocin injection-induced type 2 diabetic rats. J Exp Pharmacol. 12:27–38. 2020. View Article : Google Scholar : PubMed/NCBI

99 

Ismail AMZ, Sargowo D, Tjahjono CT, Widito S, Rizal A and Rahimah AF: The role of Garcinia mangostana pericarp extract as antioxidant to inhibit atherosclerosis process in high risk framingham score patient; original article. Heart Sci J. 2:25–29. 2021. View Article : Google Scholar

100 

Adiputro DL, Khotimah H, Widodo MA, Romdoni R and Sargowo D: Effects of ethanolic extracts of Garcinia mangostana fruit pericap on oxidant-antioxidant status and foam cells in atherosclerotic rats. Oxid Antioxid Med Sci. 2:61–64. 2013. View Article : Google Scholar

101 

Wihastuti TA, Widodo MA, Heriansyah T and Sari NAK: Study of the inhibition effect of ethanolic extract of mangosteen pericarp on atherogenesis in hypercholesterolemic rat. Asian Pac J Trop Dis. 5:830–834. 2015. View Article : Google Scholar

102 

Wihastuti TA, Aini FN, Tjahjono CT and Heriansyah T: Dietary ethanolic extract of mangosteen pericarp reduces VCAM-1, perivascular adipose tissue and aortic intimal medial thickness in hypercholesterolemic rat model. Open Access Maced J Med Sci. 7:3158–3163. 2019. View Article : Google Scholar

103 

Mittal M, Siddiqui MR, Tran K, Reddy SP and Malik AB: Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 20:1126–1167. 2014. View Article : Google Scholar :

104 

He F, Antonucci L and Karin M: NRF2 as a regulator of cell metabolism and inflammation in cancer. Carcinogenesis. 41:405–416. 2020. View Article : Google Scholar : PubMed/NCBI

105 

Fang Y, Su T, Qiu X, Mao P, Xu Y, Hu Z, Zhang Y, Zheng X, Xie P and Liu Q: Protective effect of alpha-mangostin against oxidative stress induced-retinal cell death. Sci Rep. 6:210182016. View Article : Google Scholar : PubMed/NCBI

106 

Taguchi K and Yamamoto M: The KEAP1-NRF2 system in cancer. Front Oncol. 7:852017. View Article : Google Scholar : PubMed/NCBI

107 

Chang CC, Chen CW, Owaga E, Lee WT, Liu TN and Hsieh RH: Mangosteen concentrate drink supplementation promotes antioxidant status and lactate clearance in rats after exercise. Nutrients. 12:14472020. View Article : Google Scholar :

108 

Lazarus G, Alexander S, Kusuma GO, Wijaya K and Soetikno V: Antioxidative activities of alpha-mangostin in high-fat/high-glucose diet and streptozotocin-induced insulin-resistant rodents. J Appl Pharm Sci. 10:035–039. 2020.

109 

Harliansyah H, Rahmah NA and Kuslestari K: α-Mangosteen as An Oxidative Inhibitor in Hepatocellular Carcinoma. Indones J Cancer Chemoprevention. 12:106–113. 2021. View Article : Google Scholar

110 

Sanghvi VR, Leibold J, Mina M, Mohan P, Berishaj M, Li Z, Miele MM, Lailler N, Zhao C, de Stanchina E, et al: The oncogenic action of NRF2 depends on de-glycation by fructosamine-3-kinase. Cell. 178:807–819.e21. 2019. View Article : Google Scholar : PubMed/NCBI

111 

Reyes-Fermín LM, Avila-Rojas SH, Aparicio-Trejo OE, Tapia E, Rivero I and Pedraza-Chaverri J: The protective effect of alpha-mangostin against cisplatin-induced cell death in LLC-PK1 cells is associated to mitochondrial function preservation. Antioxidants (Basel). 8:1332019. View Article : Google Scholar

112 

Chuang CJ, Wang M, Yeh JH, Chen TC, Tsou SC, Lee YJ, Chang YY and Lin HW: The protective effects of α-mangostin attenuate sodium iodate-induced cytotoxicity and oxidative injury via mediating SIRT-3 inactivation via the PI3K/AKT/PGC-1α pathway. Antioxidants (Basel). 10:18702021. View Article : Google Scholar

113 

Ruankham W, Suwanjang W, Phopin K, Songtawee N, Prachayasittikul V and Prachayasittikul S: Modulatory effects of alpha-mangostin mediated by SIRT1/3-FOXO3a pathway in oxidative stress-induced neuronal cells. Front Nutr. 8:7144632022. View Article : Google Scholar : PubMed/NCBI

114 

Zhang J, Xiang H, Liu J, Chen Y, He RR and Liu B: Mitochondrial sirtuin 3: New emerging biological function and therapeutic target. Theranostics. 10:8315–8342. 2020. View Article : Google Scholar : PubMed/NCBI

115 

Hotamisligil GS, Shargill NS and Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science. 259:87–91. 1993. View Article : Google Scholar : PubMed/NCBI

116 

Halberg N, Wernstedt-Asterholm I and Scherer PE: The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am. 37:753–768. 2008. View Article : Google Scholar : PubMed/NCBI

117 

Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS and Obin MS: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 46:2347–2355. 2005. View Article : Google Scholar : PubMed/NCBI

118 

Trayhurn P and Wood IS: Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 92:347–355. 2004. View Article : Google Scholar : PubMed/NCBI

119 

Ellulu MS, Patimah I, Khaza'ai H, Rahmat A and Abed Y: Obesity and inflammation: The linking mechanism and the complications. Arch Med Sci. 13:851–863. 2017. View Article : Google Scholar : PubMed/NCBI

120 

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X and Zhao L: Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 9:7204–7218. 2017. View Article : Google Scholar

121 

Yin P, Zou W, Li J, Jin N, Gao Q and Liu F: Using high-throughput sequencing to explore the anti-inflammatory effects of α-mangostin. Sci Rep. 9:156262019. View Article : Google Scholar

122 

Zou W, Yin P, Shi Y, Jin N, Gao Q, Li J and Liu F: A novel biological role of α-mangostin via TAK1-NF-κB pathway against inflammatory. Inflammation. 42:103–112. 2019. View Article : Google Scholar

123 

Mohan S, Syam S, Abdelwahab SI and Thangavel N: An anti-inflammatory molecular mechanism of action of α-mangostin, the major xanthone from the pericarp of Garcinia mangostana: an in silico, in vitro and in vivo approach. Food Funct. 9:3860–3871. 2018. View Article : Google Scholar : PubMed/NCBI

124 

Dong BM, Abano JB and Egan TM: Nitric oxide ventilation of rat lungs from non-heart-beating donors improves posttransplant function. Am J Transplant. 9:2707–2715. 2009. View Article : Google Scholar : PubMed/NCBI

125 

Widowati W, Darsono L, Suherman J, Fauziah N, Maesaroh M and Erawijantari PP: Anti-inflammatory effect of mangosteen (Garcinia mangostana L.) peel extract and its compounds in LPS-induced RAW264.7 cells. Nat Prod Sci. 22:147–153. 2016. View Article : Google Scholar

126 

Franceschelli S, Pesce M, Ferrone A, Patruno A, Pasqualone L, Carlucci G, Ferrone V, Carlucci M, de Lutiis MA, Grilli A, et al: A novel biological role of α-mangostin in modulating inflammatory response through the activation of SIRT-1 signaling pathway. J Cell Physiol. 231:2439–2451. 2016. View Article : Google Scholar : PubMed/NCBI

127 

Sugiyanto Z, Yohan B, Hadisaputro S, Dharmana E, Suharti C, Winarto, Djamiatun K, Rahmi FL and Sasmono RT: Inhibitory effect of alpha-mangostin to dengue virus replication and cytokines expression in human peripheral blood mononuclear cells. Nat Prod Bioprospect. 9:345–349. 2019. View Article : Google Scholar : PubMed/NCBI

128 

Yin Q, Wu YJ, Pan S, Wang DD, Tao MQ, Pei WY and Zuo J: Activation of cholinergic anti-inflammatory pathway in peripheral immune cells involved in therapeutic actions of α-mangostin on collagen-induced arthritis in rats. Drug Des Devel Ther. 14:1983–1993. 2020. View Article : Google Scholar :

129 

Tarasuk M, Songprakhon P, Chimma P, Sratongno P, Na-Bangchang K and Yenchitsomanus PT: Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression. Virus Res. 240:180–189. 2017. View Article : Google Scholar : PubMed/NCBI

130 

Yongpitakwattana P, Morchang A, Panya A, Sawasdee N and Yenchitsomanus PT: Alpha-mangostin inhibits dengue virus production and pro-inflammatory cytokine/chemokine expression in dendritic cells. Arch Virol. 166:1623–1632. 2021. View Article : Google Scholar : PubMed/NCBI

131 

Herrera-Aco DR, Medina-Campos ON, Pedraza-Chaverri J, Sciutto-Conde E, Rosas-Salgado G and Fragoso-González G: Alpha-mangostin: Anti-inflammatory and antioxidant effects on established collagen-induced arthritis in DBA/1J mice. Food Chem Toxicol. 124:300–315. 2019. View Article : Google Scholar

132 

Zuo J, Yin Q, Wang YW, Li Y, Lu LM, Xiao ZG, Wang GD and Luan JJ: Inhibition of NF-κB pathway in fibroblast-like synoviocytes by α-mangostin implicated in protective effects on joints in rats suffering from adjuvant-induced arthritis. Int Immunopharmacol. 56:78–89. 2018. View Article : Google Scholar : PubMed/NCBI

133 

Pan T, Wu D, Cai N, Chen R, Shi X, Li B and Pan J: Alpha-mangostin protects rat articular chondrocytes against IL-1β-induced inflammation and slows the progression of osteoarthritis in a rat model. Int Immunopharmacol. 52:34–43. 2017. View Article : Google Scholar : PubMed/NCBI

134 

Xu Y, Zhou H and Cai L: Alpha-mangostin attenuates oxidative stress and inflammation in adjuvant-induced arthritic rats. Trop J Pharm Res. 16:2611–2616. 2017. View Article : Google Scholar

135 

Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ and Ting JP: Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 12:408–415. 2011. View Article : Google Scholar : PubMed/NCBI

136 

Duan Y, Zeng L, Zheng C, Song B, Li F, Kong X and Xu K: Inflammatory links between high fat diets and diseases. Front Immunol. 9:26492018. View Article : Google Scholar : PubMed/NCBI

137 

Nava Catorce M, Acero G, Pedraza-Chaverri J, Fragoso G, Govezensky T and Gevorkian G: Alpha-mangostin attenuates brain inflammation induced by peripheral lipopolysaccharide administration in C57BL/6J mice. J Neuroimmunol. 297:20–27. 2016. View Article : Google Scholar : PubMed/NCBI

138 

Yang Z, Yin Q, Olatunji OJ, Li Y, Pan S, Wang DD and Zuo J: Activation of cholinergic anti-inflammatory pathway involved in therapeutic actions of α-mangostin on lipopolysaccharide-induced acute lung injury in rats. Int J Immunopathol Pharmacol. 34:20587384209549412020. View Article : Google Scholar

139 

Tatiya-Aphiradee N, Chatuphonprasert W and Jarukamjorn K: Anti-inflammatory effect of Garcinia mangostana Linn. pericarp extract in methicillin-resistant Staphylococcus aureus-induced superficial skin infection in mice. Biomed Pharmacother. 111:705–713. 2019. View Article : Google Scholar : PubMed/NCBI

140 

Lim YK, Yoo SY, Jang YY, Lee BC, Lee DS and Kook JK: Anti-inflammatory and in vitro bone formation effects of Garcinia mangostana L. and propolis extracts. Food Sci Biotechnol. 29:539–548. 2020. View Article : Google Scholar : PubMed/NCBI

141 

Xie Z, Sintara M, Chang T and Ou B: Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: A randomized, double-blind, placebo-controlled clinical trial. Food Sci Nutr. 3:342–348. 2015. View Article : Google Scholar : PubMed/NCBI

142 

Chitchumroonchokchai C, Thomas-Ahner JM, Li J, Riedl KM, Nontakham J, Suksumrarn S, Clinton SK, Kinghorn AD and Failla ML: Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites. Mol Nutr Food Res. 57:203–211. 2013. View Article : Google Scholar

143 

Nelli GB, K AS and Kilari EK: Antidiabetic effect of α-mangostin and its protective role in sexual dysfunction of streptozotocin induced diabetic male rats. Syst Biol Reprod Med. 59:319–328. 2013. View Article : Google Scholar : PubMed/NCBI

144 

Choi YH, Han SY, Kim YJ, Kim YM and Chin YW: Absorption, tissue distribution, tissue metabolism and safety of α-mangostin in mangosteen extract using mouse models. Food Chem Toxicol. 66:140–146. 2014. View Article : Google Scholar : PubMed/NCBI

145 

Kittipaspallop W, Taepavarapruk P, Chanchao C and Pimtong W: Acute toxicity and teratogenicity of α-mangostin in zebrafish embryos. Exp Biol Med (Maywood). 243:1212–1219. 2018. View Article : Google Scholar

146 

Fajeriyati N, Muchtaridi M and Sopyan I: Methods For improving alpha-mangostin solubility: A review. Int J Appl Pharm. 13:47–54. 2021. View Article : Google Scholar

147 

Aisha AF, Ismail Z, Abu-Salah KM and Majid AM: Solid dispersions of α-mangostin improve its aqueous solubility through self-assembly of nanomicelles. J Pharm Sci. 101:815–825. 2012. View Article : Google Scholar

148 

Savjani KT, Gajjar AK and Savjani JK: Drug solubility: Importance and enhancement techniques. ISRN Pharm. 2012:1957272012.PubMed/NCBI

149 

Wathoni N, Rusdin A, Motoyama K, Joni IM, Lesmana R and Muchtaridi M: Nanoparticle drug delivery systems for α-mangostin. Nanotechnol Sci Appl. 13:23–36. 2020. View Article : Google Scholar :

150 

Li L, Han AR, Kinghorn AD, Frye RF, Derendorf H and Butterweck V: Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats. Plant Med. 79:646–653. 2013. View Article : Google Scholar

151 

Foti RS, Pearson JT, Rock DA, Wahlstrom JL and Wienkers LC: In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract. Drug Metab Dispos. 37:1848–1855. 2009. View Article : Google Scholar : PubMed/NCBI

152 

Kondo M, Zhang L, Ji H, Kou Y and Ou B: Bioavailability and antioxidant effects of a xanthone-rich mangosteen (Garcinia mangostana) product in humans. J Agric Food Chem. 57:8788–8792. 2009. View Article : Google Scholar : PubMed/NCBI

153 

Singhal S, Hasan N, Nirmal K, Chawla R, Chawla S, Kalra BS and Dhal A: Bioavailable turmeric extract for knee osteoarthritis: A randomized, non-inferiority trial versus paracetamol. Trials. 22:1052021. View Article : Google Scholar : PubMed/NCBI

154 

Bumrungpert A, Kalpravidh RW, Suksamrarn S, Chaivisuthangkura A, Chitchumroonchokchai C and Failla ML: Bioaccessibility, biotransformation, and transport of alpha-mangostin from Garcinia mangostana (mangosteen) using simulated digestion and Caco-2 human intestinal cells. Mol Nutr Food Res. 53(Suppl 1): S54–S61. 2009. View Article : Google Scholar : PubMed/NCBI

155 

Chitchumroonchokchai C, Riedl KM, Suksumrarn S, Clinton SK, Kinghorn AD and Failla ML: Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. J Nutr. 142:675–680. 2012. View Article : Google Scholar : PubMed/NCBI

156 

Rukthong P, Sereesongsang N, Kulsirirat T, Boonnak N and Sathirakul K: In vitro investigation of metabolic fate of α-mangostin and gartanin via skin permeation by LC-MS/MS and in silico evaluation of the metabolites by ADMET predictor™. BMC Complement Med Ther. 20:3592020. View Article : Google Scholar

157 

Thassu D, Pathak Y and Deleers M: Nanoparticulate drug-delivery systems: An overview Nanoparticulate drug delivery systems. CRC Press; Boca Raton, FL: pp. 1–31. 2007

158 

Usman F, Shah HS, Zaib S, Manee S, Mudassir J, Khan A, Batiha GE, Abualnaja KM, Alhashmialameer D and Khan I: Fabrication and biological assessment of antidiabetic α-mangostin loaded nanosponges: In vitro, in vivo, and in silico studies. Molecules. 26:66332021. View Article : Google Scholar

159 

Sodalee K, Sapsuphan P, Wongsirikul R and Puttipipatkhachorn S: Preparation and evaluation of alpha-mangostin solid self-emulsifying drug delivery system. Asian J Pharm Sci. 11:225–226. 2016. View Article : Google Scholar

160 

Xu WK, Jiang H, Yang K, Wang YQ, Zhang Q and Zuo J: Development and in vivo evaluation of self-microemulsion as delivery system for α-mangostin. Kaohsiung J Med Sci. 33:116–123. 2017. View Article : Google Scholar : PubMed/NCBI

161 

Mahmudah R, Adnyana IK and Sukandar EY: Molecular docking studies of α-mangostin, γ-mangostin, and xanthone on peroxisome proliferator-activated receptor gamma diphenyl peptidase-4 enzyme, and aldose reductase enzyme as an antidiabetic drug candidate. J Adv Pharm Technol Res. 12:196–208. 2021. View Article : Google Scholar : PubMed/NCBI

162 

Sunitha J, Mahendra J, Mahendra L and Devaraj N: Molecular docking studies of a-mangostin with oral cancer targets ARRB1, FLNA, CALM3 and HTT. Bioinformation. 16:625–630. 2020. View Article : Google Scholar : PubMed/NCBI

163 

Herz CT and Kiefer FW: Adipose tissue browning in mice and humans. J Endocrinol. 241:R97–R109. 2019. View Article : Google Scholar : PubMed/NCBI

164 

Choi H, Kim CS and Yu R: Quercetin upregulates uncoupling protein 1 in white/brown adipose tissues through sympathetic stimulation. J Obes Metab Syndr. 27:102–109. 2018. View Article : Google Scholar

165 

Wang S, Liang X, Yang Q, Fu X, Zhu M, Rodgers BD, Jiang Q, Dodson MV and Du M: Resveratrol enhances brown adipocyte formation and function by activating AMP-activated protein kinase (AMPK) α1 in mice fed high-fat diet. Mol Nutr Food Res. 61: View Article : Google Scholar : 2017.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
John OD, Mushunje AT, Surugau N and Guad RM: The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review). Int J Mol Med 50: 120, 2022.
APA
John, O.D., Mushunje, A.T., Surugau, N., & Guad, R.M. (2022). The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review). International Journal of Molecular Medicine, 50, 120. https://doi.org/10.3892/ijmm.2022.5176
MLA
John, O. D., Mushunje, A. T., Surugau, N., Guad, R. M."The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review)". International Journal of Molecular Medicine 50.3 (2022): 120.
Chicago
John, O. D., Mushunje, A. T., Surugau, N., Guad, R. M."The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review)". International Journal of Molecular Medicine 50, no. 3 (2022): 120. https://doi.org/10.3892/ijmm.2022.5176
Copy and paste a formatted citation
x
Spandidos Publications style
John OD, Mushunje AT, Surugau N and Guad RM: The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review). Int J Mol Med 50: 120, 2022.
APA
John, O.D., Mushunje, A.T., Surugau, N., & Guad, R.M. (2022). The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review). International Journal of Molecular Medicine, 50, 120. https://doi.org/10.3892/ijmm.2022.5176
MLA
John, O. D., Mushunje, A. T., Surugau, N., Guad, R. M."The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review)". International Journal of Molecular Medicine 50.3 (2022): 120.
Chicago
John, O. D., Mushunje, A. T., Surugau, N., Guad, R. M."The metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review)". International Journal of Molecular Medicine 50, no. 3 (2022): 120. https://doi.org/10.3892/ijmm.2022.5176
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team